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Objective: To determine the stability and reproducibility of the sodium magnetic resonance imaging
(MRI) signal measured in the articular cartilage of the knee in both healthy volunteers and osteoarthritis
(OA) patients.
Design: This was a prospective Research Ethics Committee approved study that acquired sodium and
proton MRI data from 15 subjects with OA (three males, age 64  10) and ﬁve healthy controls age and
sex matched over the group. Each subject underwent standing planar radiographs of their knees for
radiological scoring as well as symptomatological assessment questionnaires. In two MRI sessions on the
same day, high resolution double-echo steady state (DESS) and 3D short echo time sodium MRI images of
the most diseased knee were acquired and co-registered in each session. A blinded reader (LT) manually
delineated the articular cartilage into four discrete regions, and two combined regions, on the DESS
images. These regions were applied to the sodium images, and a median sodium signal from each re-
ported. Within-subject and between-subject coefﬁcients of variation were estimated and intraclass
correlation coefﬁcients for the healthy control group, OA subject group, and all pooled subjects group
were calculated.
Results: Within-subject variability of sodium MRI at 3 T was 3.2% overall, and 2.0% in healthy
age-matched volunteers compared to a reproducibility of 3.6% on OA subjects.
Conclusions: The reproducibility of sodium MRI was similar in both healthy controls and OA subjects.
Researchers piloting techniques in healthy controls thus may expect a similar reproducibility in a controlled
trial involving subjects with American College of Rheumatology (ACR)-deﬁned OA of the knee.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Cartilage degeneration in osteoarthritis (OA) is characterized by
degradation of the collagen matrix and loss of extracellular
proteoglycans (PGs)1,2. PGs contain negatively charged sulfate and
carboxylate groups, which constitute a ﬁxed charge density (FCD).R.D. Newbould, GSK Clinical
. Tel: 44-02080086264; Fax:
. Newbould).
s Research Society International. PThe Donnan equilibrium dictates that positively charged mobile
ions distribute into cartilage in proportion to this FCD. The majority
of positively charged ions in synovial ﬂuid and cartilage are sodium
(Na); which can bemeasured bymagnetic resonance imaging (MRI)
to determine the FCD3. Therefore, measuring Na in cartilagemay be
a sensitive marker for PG loss and cartilage degeneration4.
Studies using ex-vivo cartilage samples have determined that
the FCD can be determined by Na MRI3,4, and that the Na concen-
tration, and therefore the FCD, reduces with chemical degradation
of the cartilage samples by trypsin5. It has further been shown that
Na MRI is a sensitive marker of PG content, whereas proton T1, T2,
and proton density are not6.ublished by Elsevier Ltd. All rights reserved.
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and determined the Na concentration in the wrist7, and that areas
of lower Na concentration could be found in the knee cartilage of
three OA patients8. A previous study has examined the repeatability
of Na measures in four healthy volunteers9 and found a within-
subject variability of 6.6%.
A number of studies have explored the use of NaMRI of cartilage
in OA, but no study has systematically addressed the reproduc-
ibility of these measurements in a larger cohort of both healthy and
OA subjects. Therefore, in this study we sought to determine the
reproducibility of the Na MRI concentration measured in the
articular cartilage of the knee in both healthy volunteers and OA
patients. This study is a step towards validating Na MRI as
a biomarker of OA progression in a clinical cohort.Materials and methods
Patient population
A total of 20 subjects were recruited and gave informed consent
in accordance with a Research Ethics Committee (REC) approved
prospective study protocol (Redbridge andWaltham Forest REC ref:
08/H0701/87). Fifteen subjects were referred from rheumatology
and surgical clinics in the Imperial College Healthcare NHS Trust
with a conﬁrmed diagnosis of OA by the American College of
Rheumatology (ACR) guidelines10, and ﬁve were recruited as
between-group age and sex matched healthy controls. Subject
demographics are summarized in Table I.
After an initial screening and informed consent visit, all
subjects underwent a standing plane ﬁlm X-ray of both knees.
Whole-joint KellgreneLawrence (KeL) scoring11 was performed
on these X-rays by a blinded radiologist with 16 years experience.
A pain visual-analog scale (VAS) score, the International Physical
Activity score (IPAQ)12, and the Knee Injury and Osteoarthritis
Outcome Score (KOOS)13 was collected from each subject. These
clinical scoring systems were used to measure disease burden,Table I
Summary of subject characteristics
Demographics
Age Sex Height (cm) Weight (kg)
OA group
1 57 F 153 83.3
2 55 F 159 86.6
3 74 F 157 81.3
4 43 F 159 62.5
5 56 F 156 81
6 58 M 169 88.2
7 67 F 151 85.8
8 67 F 157 60.6
9 64 F 156 62.9
10 77 F 151 57.9
11 61 F 167 63
12 66 M 186 84.4
13 81 M 166 53
14 61 F 152 83.9
15 71 F 164 53
Controls
16 50 F 170 58.2
17 72 F 162 66.6
18 57 F 163 65.2
19 61 M 178 80.6
20 68 F 155 64.5
OA group 63.9 9.7 F¼ 12/15 160.2 9.2 72.5 13.5
Controls 61.6 8.7 F¼ 4/5 165.6 8.7 67.0 8.2
(P¼ 0.65) (P¼ 1.0) (P¼ 0.27) (P¼ 0.41)and are also summarized in Table I. An MRI visit then followed
within 30 days.MRI
Subjects were scanned using a Siemens 3T Tim Trio (Siemens
Healthcare, Erlangen, Germany) with a dual tuned 1H/23Na quad-
rature 18 cm diameter volume coil (Rapid Biomedical GmbH,
Rimpar, Germany). Subjects were positioned feet ﬁrst with the
patellar tendon at the magnet’s isocentre and in the middle of the
coil. Two small phantoms with Na concentrations of 150 mM and
250 mM were attached to the scanned knee within the coil for
signal normalization. A scout scan ﬁrst checked the knee’s position.
High resolution 3D structural dual-echo steady state (DESS)14 and
3D Na scans15 were acquired during each of two scanning sessions
on the same day. Subjects were removed from the scan room
between scan sessions.
The high resolution 3D sagittal 1H DESS scan was acquired for
underlying anatomical segmentation. Sequence parameters used
were: 600 mm isotropic resolution (0.216 mL voxels), ﬁeld of view
(FOV) 15  14  9.6 cm, ﬂip angle 25, repetition time (TR) ¼ 14.84
ms, echo time (TE) ¼ 5.04 ms, BW ¼ 222 Hz/pixel, primary phase
encoding anterior to posterior, and partial Fourier in both phase
encoding directions requiring a scan time of 6 min:34 s.
NaMRI images were acquired using an ultra short TE 3D cones16
non-Cartesian spoiled gradient echo sequence. Sequence parame-
ters were 712 3D cones readouts of 1,152 points acquired over
7.5 ms for a ﬁnal isotropic resolution of 2.5 mm (15.625 mL voxels)
in an 18 cm FOV, with a TR of 15 ms, TE¼ 270 ms, and a nominal ﬂip
angle of 70, with 118 averages acquired in 21 min. Data were
reconstructed via a 3D regridding reconstruction that oversampled
the Cartesian grid by a factor of three.
Na concentration images, [Na] were calculated using the mean
signal in the stronger of the two reference vials, SVIAL, the known
concentration of the vial, [Vial], of 250 mM, the T1 of the vial
measured via saturation recovery, T1VIAL, the ﬂip angle a, and anClinical scores
BMI KeL KOOS Pain VAS IPAQ
35.6 3 140 10 2
34.3 3 76 3 3
33.0 2 160 6 2
24.7 2 163 7 2
33.3 4 167 8 3
30.9 3 158 6 3
37.6 4 160 5 1
24.6 0 76 4 3
25.8 3 111 4 3
25.4 4 137 7 3
22.6 0 105 2 3
24.4 3 79 3 2
19.2 3 146 7 1
36.3 2 155 7 3
19.7 3 132 4 3
20.1 0 42 0 3
25.4 2 45 0 3
24.5 0 43 0 3
25.4 3 44 0 3
26.8 1 44 0 3
28.5 6.2 2.6 1.2 131 33 5.5 2.2 2.5 0.7
24.5 2.6 1.2 1.3 44 1 0.0 0.0 3.0 0.0
(P¼ 0.18) (P¼ 0.071) (P< 0.0001) (P¼ 0.0040) (P¼ 0.13)
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[1]
3D images were ﬁnally scaled using an afﬁne transformation
calibrated on a resolution phantom (data not shown) to partially
account for gradient non-linearities19 that were corrected for the
Cartesian sequences, such as the 3D DESS, with the manufacturer
provided warping ﬁeld.
Structural T1, T2, and proton density scans were also acquired in
one of the scan sessions for radiological review to rule out other
pathologies.Data analysis
The knee cartilage was delineated on the 3D DESS images and
manually segmented by a blinded reader using Analyze (Mayo
Clinic BIR, Rochester, Minnesota, USA) into four discrete cartilage
zones: Medial and Lateral Tibio-Femoral (MTF and LTF), and Medial
and Lateral Patello-Femoral (MPF and LPF) regions of interest
(ROIs). Two further ROIs were deﬁned that were the union of the
medial and lateral compartments of the Patello-Femoral (PF), and
Tibio-Femoral (TF) cartilage. The MTF and LTF cartilage was deﬁned
as the cartilage covering the medial and lateral condyles up to the
intratrochanteric fossa. The boundary of the MPF and LPF cartilage
was deﬁned by a vertical line drawn halfway between the medial
border of the lateral femoral condyle and the lateral border of the
medial femoral condyle. An example of these regions is illustrated
in Fig. 1. The DESS structural image was then co-registered with the
Na MR image using the rigid-body registration in spm8 (FIL, Insti-
tute of Neurology, London, UK) to correct for any patient movement
between the scans. The co-registrationwas checked both visually as
well as by generating histograms of segmented Na concentrations
both before and after the co-registration routine. Given that the
cartilage voxels should reﬂect the strongest Na concentration,
co-registration was considered successful if the median of the
distribution increased and the standard deviation decreased.
Co-registration for three datasets was problematic due towrapping
of the most lateral vial in the slab dimension in the 3D DESSFig. 1. Example imaging data from a subject with OA. (a) Standing radiograph of the right kn
and LTF are in purple and cyan, respectively, while MPF and LPF is in green and brown, resvolume. In these cases, slices containing vial intensity wrapping
around from the opposite side of the slab were dropped from the
volume, the registration was performed, and then the dropped
slices were transformed and added back to the registered space.
The derived cartilage ROIs were transformed into the Na image
space and overlaid on the Na images. Volumes and the median Na
concentration in each ROI were calculated for each Na scan.
Statistical methods
Group demographics were analyzed for group differences as
reported in Table I. Body mass index (BMI), height, weight, and
KOOS scores were compared using the Student’s t-test. Sex
frequencies were compared with Fisher’s exact test. The Wilcoxon
rank sum test was used for KeL score, pain VAS, and IPAQ score. All
tests were two-tailed.
Na testeretest was analyzed with both the median Na concen-
tration and the ROI volume for each ROI deﬁned as well as thewhole
cartilage in each group. For each ROI measure two testeretest
statistics were calculated. Measures were log-transformed prior to
analysis, and statistics were back-transformed onto a percentage
scale. The within-subject coefﬁcient of variation (CVw) was esti-
mated from a mixed model with no ﬁxed effects and a random
subject effect to split the variance into two components, within-
subject and between-subject (CVB). The intraclass correlation coef-
ﬁcient (ICC) was estimated as CVB/(CVBþ CVw) with 95% conﬁdence
intervals (CIs) using the methods of Shrout and Fleiss for one-way
random effects (case 1)20. As a separate visual analysis, plots were
produced displaying estimated bias and limits of agreement (LoA)
between scan 2 and scan 1 calculated using the methods of Bland
and Altman21,22. The CIs were calculated for the CVw using Sat-
terthwaite’s approximation23.
To examine whether there was any evidence of different CVw
and ICC values in the OA subjects and healthy controls, mixed
models were ﬁtted with additional parameters which allowed the
variance components to take different values in the two groups. The
goodness of ﬁt, as measured by the Akaike information criterion
with a correction for ﬁnite sample sizes (AICc)24, was examined. If
themodel withmore parameters had a lower AICc this was taken as
evidence that the testeretest statistic differed between the groups.
Results
Patient population
As seen in Table I, both groups are well matched as being
predominantly female and typically aged in their early 60’s, with noee shows a medial cartilage defect. (bee) 3D DESS images with the ROIs overlaid. MTF
pectively. (f) Na images overlaid on the DESS, transformed into the Na space.
Table III
Testeretest statistics, with 95% CIs in parentheses, for the Na concentration and ROI
volumes for the group containing only the healthy controls
ROI % CVw ICC
Median Na concentration WHOLE 2.0 (1.3, 5.0) 0.96 (0.75, 1.00)
PF 4.0 (2.5, 9.9) 0.91 (0.48, 0.99)
TF 2.2 (1.4, 5.5) 0.96 (0.72, 1.00)
LPF 3.1* (1.9, 7.6) 0.93 (0.58, 0.99)
MPF 13.8* (8.6, 34.7) 0.80y (0.09, 0.98)
LTF 4.2 (2.6, 10.3) 0.89 (0.38, 0.99)
MTF 3.1 (2.0, 7.7) 0.93 (0.60, 0.99)
Volume WHOLE 7.5 (4.7, 18.6) 0.64y (0.23, 0.95)
PF 5.5 (3.4, 13.4) 0.92 (0.53, 0.99)
TF 10.1 (6.3, 25.2) 0.61y (0.29, 0.95)
LPF 16.5* (10.3, 42.0) 0.65y (0.22, 0.96)
MPF 62.2* (36.9, 248.1) 0.23y (0.64, 0.88)
LTF 10.4 (6.5, 25.9) 0.73 (0.08, 0.97)
MTF 13.7 (8.5, 34.5) 0.57y (0.34, 0.94)
* CVw differs between the OA and healthy control groups.
y ICC differs between the OA and healthy control groups.
Table IV
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in contrast with the clinical measures of disease severity, also in
Table I. The pain VAS was signiﬁcantly different (P¼ 0.0040)
between groups. As pain is one of elements of the ACR criteria
deﬁning OA, this could be expected. The KOOS scoring was also
highly signiﬁcantly different (P< 0.0001), which stands in contrast
to the IPAQ and KeL scoring methods. Whole-knee KeL scoring
approached but did not achieve signiﬁcance (deﬁned as P< 0.05)
between groups. While caution must be exercised in comparing
P-values from different tests, overlap in scores is notable between
the groups: two OA subjects had the lowest possible KeL score of 0,
and one control had a high KeL score of 3. Given the strong
differences between groups in reported pain and KOOS scores, this
may reﬂect shortcomings in whole-knee KeL scores as well as
heterogeneity of the disease. The activity scoring was still further
from signiﬁcance (P¼ 0.13) andmay reﬂect the limited scope of the
scoring system, e.g., that it reﬂects only activity rather than clinical
criteria for the etiology of OA.
Na repeatability
An example dataset from an OA subject is shown in Fig. 1. The
standing X-ray shows an obvious medial joint space narrowing. The
defect is apparent on the 3D DESS images, and can be appreciated
here in Fig. 1(d), where the gap in the MTF ROI in purple highlights
the lack of cartilage. Na images are shown overlaid on the DESS,
which has been transformed into the Na space. High Na signal can
be appreciated in the cartilage, with little signal elsewhere aside
from in the external reference vials.
Repeatability measures for the Na concentration in the cartilage
ROIs are summarized in Table II for the total study group. Overall,
a 3.2% CVw was found for the median Na concentration over the
total cartilage studied. The TF cartilage was more repeatable than
the PF cartilage, which is also reﬂected in comparisons between
both the medial and lateral sub-ROIs. This trend is shown in both
OA and healthy subjects. The volume measurements showed a 5.8%
CVw across all subjects, yet was slightly lower (5.0%) in the OA
subjects only. Repeatability measures for the volume of the carti-
lage ROIs are reported in the lower half of Table II. As could be
expected, the measurement was less stable for smaller ROIs than
for larger ROIs. Unlike the Na signal, the repeatability was higher in
the PF cartilage than in the TF cartilage.
Overall, there was little difference in the repeatability measures
of each group separately, as summarized in Tables III and IV. For
both Na concentration and volumemeasures the AICc was generally
lower when the CVw was assumed to be the same for both OA
subjects and healthy controls, with evidence of different variabilityTable II
Testeretest statistics, with 95% CIs in parentheses, for the Na concentration and ROI
volumes for the group containing all subjects
ROI % CVw ICC
Median Na concentration WHOLE 3.2 (2.5, 4.7) 0.91 (0.79, 0.96)
PF 5.9 (4.5, 8.6) 0.84 (0.63, 0.93)
TF 2.5 (1.9, 3.7) 0.95 (0.89, 0.98)
LPF 6.0 (4.6, 8.8) 0.86 (0.68, 0.94)
MPF 9.9 (7.5, 14.5) 0.67 (0.33, 0.86)
LTF 4.1 (3.1, 6.0) 0.88 (0.72, 0.95)
MTF 3.6 (2.7, 5.2) 0.94 (0.86, 0.98)
Volume WHOLE 5.8 (4.4, 8.5) 0.95 (0.88, 0.98)
PF 4.7 (3.6, 6.9) 0.98 (0.95, 0.99)
TF 7.4 (5.6, 10.8) 0.95 (0.88, 0.98)
LPF 10.4 (7.9, 15.2) 0.97 (0.92, 0.99)
MPF 34.8 (26.1, 52.6) 0.85 (0.66, 0.94)
LTF 9.6 (7.3, 14.1) 0.86 (0.68, 0.94)
MTF 13.8 (10.5, 20.3) 0.95 (0.88, 0.98)between the populations only in the smallest ROIs (LPF and MPF).
Similar results were seen for the ICC statistic with Na concentra-
tion. However, AICc was lower when the ICC was allowed to be
different between the OA and healthy groups than themodel which
constrained the ICC to be the same in both groups for the volume
measures in most ROIs. This appears to be primarily driven by
increased between-subject variability in the OA subjects, presum-
ably due to differential disease progression, which in turn results in
smaller ICCs in this group than the healthy controls. The
BlandeAltman plots in Figs. 2 and 3 for the volume and Na
measurements, respectively, more clearly show the similarities
between the groups. The bias lines and 95% LoA are similar for each
group in all the plots. Overall, these results support the conclusion
that the repeatability of Nameasurements is very similar in healthy
and OA subjects.
Discussion
This study quantiﬁed the testeretest variability of Na imaging of
the knee in OA subjects. The testeretest reliability was similar
between healthy controls and OA subjects. This is a major ﬁnding of
the study, as it shows that Na methods, which are still generally
performed only in a research setting piloted in healthy controls,
would have a similar stability when applied to subjects with
cartilage degeneration. One may have expected a greater variability
in the cartilage of OA subjects due to the expectation of moreTesteretest statistics, with 95% CIs in parentheses, for the Na concentration and ROI
volumes for the group containing only OA subjects
ROI % CVw ICC
Median Na concentration WHOLE 3.6 (2.6, 5.6) 0.89 (0.71, 0.96)
PF 6.5 (4.7, 10.2) 0.82 (0.53, 0.94)
TF 2.6 (1.9, 4.1) 0.95 (0.86, 0.98)
LPF 6.8* (5.0, 10.7) 0.85 (0.61, 0.95)
MPF 8.0* (5.9, 12.7) 0.40y (0.13, 0.76)
LTF 4.1 (3.0, 6.4) 0.87 (0.66, 0.96)
MTF 3.7 (2.7, 5.8) 0.95 (0.84, 0.98)
Volume WHOLE 5.0 (3.7, 7.9) 0.97y (0.91, 0.99)
PF 4.4 (3.3, 7.0) 0.98 (0.96, 1.00)
TF 6.1 (4.5, 9.6) 0.97y (0.92, 0.99)
LPF 7.0* (5.1, 11.1) 0.99y (0.97, 1.00)
MPF 19.8* (14.4, 31.6) 0.96y (0.88, 0.99)
LTF 9.3 (6.8, 14.7) 0.89 (0.69, 0.96)
MTF 13.9 (10.1, 22.0) 0.96y (0.89, 0.99)
* CVw differs between the OA and healthy control groups.
y ICC differs between the OA and healthy control groups.
Fig. 2. BlandeAltman plots of volume measurements. Both OA subjects (circles) and healthy controls (squares) are included in each plot, which shows similar bias and LoA in both
groups in the whole knee volume (a), PF (b), medial (c) and lateral (d) TF cartilage ROIs.
R.D. Newbould et al. / Osteoarthritis and Cartilage 20 (2012) 29e35 33variable cartilage volumes, lower Na concentrations, and problems
in reliably positioning subjects with OA.
The scanning protocol used in this study was designed for
potential use in a clinical trial. Therefore, scanning times were
limited to those thought to be short enough to be well tolerated by
OA subjects. This resulted in a scan time of 21 min for the Na signal,
in order to keep the total scan time including subject positioning
and structural scanning under 1 h.
The Na measures used in this study were cross-scan reference
phantom calibrated Na concentration values. The use of a birdcage
volume coil for excitation and reception of the Na signal obviates
the need to perform B1 mapping. The use of a surface coil can
locally increase the signal to noise ratio (SNR) at the penalty of the
need to correct for spatial variation in the achieved radiofrequency
(RF) excitation ﬂip angle and signal reception sensitivity. These
values were corrected for incomplete T1 recovery, however, as with
most studies, only a single T1 value for the entire population8 was
used. Therefore, this correction did not change the testeretestFig. 3. BlandeAltman plots of cartilage Na measurements. Both OA subjects (circles) and he
both groups in the whole knee (a) median Na values, as well as the PF (b), medial (c) andstatistics. As the Na T1 is in the range of 14e20 ms5,8,17,18, the
acquisition was not strongly T1-weighted in the cartilage. An
increase in the Na T1 relaxation time, as seen in chemically
degraded cartilage samples17, would cause an underestimation of
the Na concentration, which in this study was found to be between
207 and 315 mM over all subjects. No change in the T1 could be
expected between scan visits due to the short duration. The FCD
could further be calculated, but again the testeretest statistics
remain valid. The quadrupolar relaxation of Na results in two
exponential T2 decays in non-ﬂuid compartments. In cartilage the
rapid decay is on the order of 1 ms and is experienced by 60% of the
spins, with a slower T2 decay on the order of 10 ms experienced by
40% of the spins. A longer TE, on the order of several ms, will only
image 40% of the total spins, and may experience a seemingly
paradoxical increase of Na density as the cartilage becomes more
ﬂuid-like. In this work a short echo time of 270 ms was used to
minimize T2* weighting and to capture both rapidly and slowly
relaxing components. As a result of the innate lower Na signal, thealthy controls (squares) are included in each plot, which shows similar bias and LoA in
lateral (d) TF cartilage ROIs.
R.D. Newbould et al. / Osteoarthritis and Cartilage 20 (2012) 29e3534in-plane resolution of the Na scans was approximately four times
lower than in the DESS scans, which may increase sensitivity to
partial volume effects.
It was seen that there is a greater variability in the volume
measures of the ROIs than in the Na measures. This may be due to
deﬁnition of the ROIs on the higher resolution 1H structural scans,
which were then registered and downsampled to the lower reso-
lution 23Na scans for the Na measures. Further, medial and lateral
components of the ROIs had similar Na concentration levels, which
would also obviate changes in the discrimination between these
two sub-ROIs. No variability could be attributed to disease
progression due to the short time between the scans, all pairs of
which were performed on the same day.
The ROIs were deﬁned by a single reader, therefore no inter-
reader agreement statistics were examined. Therefore it is
unknown whether there is a bias introduced by the choice of
reader. This study examined inter-scan variability, which will be
inherent to any study using this technique, rather than inter-reader
reproducibility. If Na imaging is a highly sensitive biomarker for OA
progression, studies using Na imaging could use fewer subjects
with a single reader, obviating the need to include reader
dependence.
The population recruited to this study came from the setting of
secondary care clinics and this is reﬂected in the relatively
advanced osteoarthritic changes in the disease cohort based on
symptoms or radiography. If Na signal reﬂects PG concentration, it
would be expected that this population would show the strongest
signal decline. Unlike previous studies of Na in knee cartilage8, this
study did not pre-select areas of low Na concentration to compare
against mean values in healthy volunteers. Indeed, the ROIs were
deﬁned on the structural image, and only selected areas of cartilage.
That is, the ROIs would avoid any missing cartilage. In this more
advanced OA cohort, a number of full-thickness cartilage defects
were noted in both structural and Na imaging. The ROIs thus
excluded these areas of missing cartilage.
In the case of the age-matched, asymptomatic control group, it
emerged that some patients had radiographic features of OA
despite the absence of symptoms. This observation illustrates what
has long been known regarding the heterogeneity of symptom-
atology in OA and that a degree of tissue degeneration appears to be
commonplace with aging. One possible solution would be to enroll
more subjects in the healthy control cohort but to then exclude
subjects from the analysis of the cohort who show radiographic
signs of OA in the data taken as part of the study. The ethically-
approved protocol used in this study did not contain such a provi-
sion, but did exclude subjects with previous history or ﬁndings of
joint disease. The inclusion of subjects with radiographic ﬁndings
in the healthy control group did not greatly affect the outcome of
this study, as a similar, good reproducibility was found in both
groups. In future work, it would be interesting to test the perfor-
mance of Na MRI in individuals with a shorter symptom duration,
who would be anticipated to have less advanced radiographic
change.
Structural measures of cartilage loss, using MRI, have been
investigated extensively. However the relationship between carti-
lage regression and OA disease progression is still unclear25. Several
other techniques that may better capture physiological changes are
actively researched. T2 mapping of cartilage reﬂects hydration
status26, but also a mixture of the tissue’s architecture, orientation,
and microstructure. T1r mapping may also be reﬂective of
glycosaminoglycan content27, though it is not speciﬁc to any
macromolecule, and may be most sensitive to collagen changes in
cartilage. Delayed Gadolinium Enhanced MRI of Cartilage
(dGEMRIC)28 works on a similar basis as Na mapping: relating the
FCD to the resistance to uptake of a negatively charged Gd contrastagent. Unlike Na ions, questions remain about ensuring the contrast
agent fully penetrates the cartilage, the sensitivity to cellularity,
and the quantitation of the agent concentration. dGEMRIC, T2 and
T1r mapping do not require specialized hardware and recon-
structions, unlike Na mapping, and can achieve a greater spatial
resolution than Na. As all three techniques can be performed on the
majority clinical systems, they therefore enjoy a greater adoption
than Na imaging. Na imaging directly images Na nuclei, which have
a lower gyromagnetic ratio and abundance than hydrogen nuclei.
This necessitates a much lower imaging resolution. Whereas the
previously noted methods can achieve high resolutions to examine
the superﬁcial-to-deep variation in the cartilage, this is not
currently possible in Na imaging.
This study represents the initial step in validating Na MRI as
a marker of cartilage degradation in subjects with a proven diag-
nosis of OA. However, further work is needed to monitor the
changes in Na MRI consistent with OA disease progression in
a longitudinal study and to further explore the differences between
OA and healthy subjects in a larger cohort. The patient numbers and
inclusion criteria in this study were designed only to determine
measurement repeatability, not differences in cartilage Na
concentration between those with OA and healthy controls. No
conclusions about these cross-sectional differences in absolute Na
concentration can be drawn from this limited dataset. Correlations
with arthroscopically obtained assessments of the location and
severity of disease using intra-articular mapping29 may also be
necessary to validate localization of altered Na measures. Response
to treatment in randomized controlled trials of patients with OA
has been measured by patient-reported assessments of pain,
function and stiffness as well as by patient and clinical global
evaluations of disease status and response30. Typically, in trials
using these measures large sample sizes are required and this leads
to expensive and time consuming studies. Developing Na MRI as
a more speciﬁc marker of cartilage degeneration may lead to an
outcome measure that has greater speciﬁcity and sensitivity to
measure responses to treatment in clinical trials of OA.
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